Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection

Genes and Immunity

Volumn 1, Issue 6, 2000, Pages 386-390

  Yee, L J ^a,b   Tang, J ^a,c   Herrera, J ^d   Kaslow, R A ^a   Van Leeuwen, D J ^b,e  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^e University of Alabama at Birmingham   (United States)

Author keywords

Cirrhosis; Fibrosis; Genetics; Hepatitis C virus; Polymorphism; Tumor necrosis factor

Indexed keywords

HEPATITIS C VIRUS;

CD4 ANTIGEN; LEUKOCYTE ANTIGEN; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; HAPLOTYPE; HEPATITIS C; HUMAN; IMMUNOLOGY; LIVER CIRRHOSIS; MALE; MIDDLE AGED; TANDEM REPEAT;

ADOLESCENT; ADULT; AGED; ALLELES; ANTIGENS, CD; ANTIGENS, CD4; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; HAPLOTYPES; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TANDEM REPEAT SEQUENCES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034252849     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363696     Document Type: Article

References (34)

1. Koretz R, Abbey H, Coleman E, Gitnick G. Non-A, non-B post-transfusion hepatitis looking back in the second decade. Ann Intern Med 1993; 119: 110-115.
2. Seeff LB, Buskell-Bales Z, Wright EC et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 1992; 327: 1906-1911.
3. DiBisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 1991; 14: 969-974.
4. Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T. Natural course of chronic hepatitis C. Am J Gastroenterol 1993; 88: 240-243.
5. Yano M, Kumada H, Kage M et al. The long-term pathological evolution of chronic hepatitis C. Hepatology 1996; 23: 1334-1340.
6. Vaquer P, Canet R, Llompart A, Riera J, Obrador A, Gayá J. Histological evolution of chronic hepatitis C. Factors related to progression. Liver 1994; 14: 265-269.
7. Pessione F, Degos F, Marcellin P et al. Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology 1998; 27: 1717-1722.
8. Wiley TE, McCarthy M, Breidi L, McCarthy M, Layden TJ. Impact of alcohol on the histological and clinical progression of hepatitis C infection. Hepatology 1998; 28: 805-809.
9. Ostapowicz G, Watson KJR, Locarnini SA, Desmond PV. Role of Alcohol in the progression of liver disease caused by hepatitis C virus infection. Hepatology 1998; 27: 1730-1735.
10. Faubion WA, Gores GJ. Death receptors in liver biology and pathobiology. Hepatology 1999; 29: 1-4.
11. Ruuls SR, Sedgwick JD. Unlinking tumor necrosis factor biology from the major histocompatability complex: lessons from human genetics and animal models. Am J Hum Genet 1999; 65: 294-301.
12. Friedman SL. Molecular mechanisms of hepatic fibrosis and principles of therapy. J Gastroenterol 1997; 32: 424-430.
13. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LBA, Duff GW. An allelic polymorphism within the human tumor necrosis factor-alpha promoter region is strongly associated with HLA Al, B8, and DR3 alleles. J Exp Med 1993; 177: 557-560.
14. D'Alfonso S, Richiardi PM. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 1994; 39: 150-154.
15. Wilson AG, di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human Tumor Necrosis Factor alpha (TNF-alpha) gene detectable by Ncol restriction PCR product. Hum Mol Genet 1992; 1: 353.
16. Wilson AG, Symons J, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-3199.
17. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-a promoter polymorphism effects transcription. Mol Immunol 1997; 34: 391-399.
18. Fanning GC, Bunce M, Black CM, Welsh KI. Polymerase chain reaction haplotyping using 3′ mismatches in the forward and reverse primers: application to the biallelic polymorphisms of tumor necrosis factor and lymphotoxin alpha. Tissue Antigens 1997; 50: 23-31.
19. Zhang M, Tracey KJ. Tumor Necrosis Factor. In: Thomsen A (ed). The Cytokine Handbook. Academic Press: London, UK, 1998, pp 517-548.
20. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-511.
21. Bernal W, Moloney M, Underhill J, Donaldson PT. Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis. J Hepatol 1999; 30: 237-241.
22. Tanaka A, Quaranta S, Mattalia A et al. The tumor necrosis factor-α promoter correlates with progression of primary biliary cirrhosis. J Hepatol 1999; 30: 826-829.
23. Khoo SH, Pepper L, Snowden N et al. Tumor necrosis factor c2 microsatellite allele is associated with the rate of HIV disease progression. AIDS 1997; 11: 423-428.
24. Brinkman BMN, Zuijdgeest D, Kaijzel EL, Breedveld FC, Verweij C. Relevance of the tumor necrosis factor alpha (TNFα)-308 promoter polymorphism in TNF-a gene regulation. J Inflamm 1996; 46: 32-41.
25. Marinos G, Naoumov NV, Rossol S et al. Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection. Gastroenterology 1995; 108: 1453-1463.
26. Höhler T, Kruger A, Gerken G, Schneider PM, zum Büschenfelde KHM, Rittner C. Tumor necrosis factor-alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infection. J Med Virol 1998; 54: 173-177.
27. Höhler T, Kruger A., Gerken G, Schneider PM, zum Büschenfelde KHM, Rittner C. A tumour necrosis factor-alpha (TNF-α) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol 1998; 111: 579-582.
28. Tishkoff SA, Dietzsch E, Speed W et al. Global patterns of linkage disequilibrium at the CD4 locus and modern human origins. Science 1996; 271: 1380-1387.
29. Yee LJ, Weiss HL, Langner RG, Herrera J, Kaslow RA, van Leeuwen DJ. Patients with chronic hepatitis C virus infection have multiple risk factors for its acquisition (submitted for publication).
30. Miller SA, Dykes DD, Polesky HF. A simple and efficient non-organic salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
31. Grimberg J, Nawoschik S, Belluscio L, McKee R, Tuck A, Eisenberg A. A simple and efficient non-organic procedure for the isolation of genomic DNA from blood. Nucleic Acids Res 1989; 17: 8390.
32. Garcia-Merino A, Alper CA, Usuku K et al. Tumor necrosis factor (TNF) microsatellite haplotypes in relation to extended haplotypes, susceptibility to diseases associated with the major histocompatibility complex and TNF secretion. Human Immunol 1996; 50: 11-21.
33. Edwards A, Hammond HA, Jin L, Caskey CT, Chakraborty R. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics 1992; 12: 241-253.
34. Edwards A, Civitello A, Hammond HA, Caskey CT. DNA typing and genetic mapping with trimeric and tetrameric tandem repeats. Am J Hum Genet 1991; 19: 746-756.